Updates on Covid-19
Merck KGaA, Darmstadt, Germany and BioNTech Extend Strategic Partnership Through Accelerated Supply of Urgently Needed Lipids
Merck KGaA, Darmstadt, Germany in close collaboration with BioNTech, will significantly accelerate the supply of urgently needed lipids and increase the amount of lipid delivery towards the end of 2021.Read more
Related NewsAll stories at a glance
Merck KGaA, Darmstadt, Germany, today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).
MilliporeSigma today announced the broadening of its manufacturing footprint with a combined $47 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire.
MilliporeSigma today announced a collaboration with Mammoth Biosciences Inc. for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test.
Human progress is what Merck stands for. During these difficult times, we actively contribute resources, full dedication and expertise to fight this Covid-19 pandemic.
Panel Discussion: Fighting the Pandemic
Stefan Oschmann, Pardis Sabeti, James Crowe and Subhanu Saxena came together virtually to exchange thoughts regarding the Covid-19 situation and share their vision for the future.Watch full recording
Research Grant for Pandemic Preparedness
The threat from newly emerging viral infections is a global challenge for humanity. We offer research grants for technological solutions towards pandemic preparedness or solutions that could help fighting emerging viral infections.Read more
Global Health in times of Covid-19
According to the World Health Organization, at least half of the world’s population does not have access to essential health care. In times of Covid-19, the most vulnerable countries will be worst affected.Read more